Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CP Pharmaceuticals, a key subsidiary of the global pharmaceutical group Wockhardt, is a UK-based manufacturer and supplier of a wide range of pharmaceutical products, including generics, biosimilars, and specialty medicines. The company operates significant manufacturing facilities in Wrexham, Wales, where it produces sterile injectables, oral solids, and various other dosage forms for both human and veterinary use. CP Pharmaceuticals is a critical component of Wockhardt's international operations, contributing to the development and commercialization of innovative antibiotics and biosimilars. Its capabilities span from large-scale contract manufacturing (CDMO) to the production of essential medicines like insulin and vaccines. The company is particularly noted for its role in Wockhardt's antimicrobial research and its supply of life-saving treatments to the NHS and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemical Products.